Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Evaluation of the Impact of Coitus on Pharmacokinetics and Pharmacodynamics of Tenofovir 1% Gel Following Pericoital or Daily Gel Dosing

NCT01687205 is registered in ClinicalTrials.gov with CONRAD as lead sponsor.

NCT NCT01687205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01687205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Evaluation of the Impact of Coitus on Pharmacokinetics and Pharmacodynamics of Tenofovir 1% Gel Following Pericoital or Daily Gel Dosing
Lead sponsor
CONRAD
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2012
Completion date
November 30, 2014
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacodynamics of 1% tenofovir gel following coitus, pharmacokinetics of 1% tenofovir gel following coitus